Skip to main content
Premium Trial:

Request an Annual Quote

MRC Establishes Venture Capital Fund to Fuel Biotechnology Startups

Premium

LONDON--The Medical Research Council (MRC) here has established a venture capital fund of between £30 million and £40 million to provide seed money for biotechnology startups. Companies that derive from MRC-sponsored research will receive 75 percent of the funding. While it has formed alliances with companies in the past, this is the MRC's first foray into backing new companies.

The enterprise, which will be called UK Medical Ventures Management, will be chaired by the MRC's David Owen. "The problem has been how to recruit management without having the money to develop a new venture," he commented. "The fund should overcome this. It will work alongside MRC's technology advances and should spark attractive developments which will prove profitable to the fund and foster successful MRC developments." Andrew Chapman of Hoare Govett, the fund's sponsor, added, "It is a significant step forward in establishing and growing biomedical research in Britain."

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.